Peyronie’s Disease in Teenagers: Is Collagenase Clostridium Histolyticum a Solution? - Abstract
INTRODUCTION
Peyronie’s disease (PD) is commonly seen in middle-aged men, and is rare in teenagers [1]. Collagenase Clostridium Histolyticum (CCH) is actually the non-surgical gold standard treatment for PD as its safety and efficacy has been demonstrated in large well-designed clinical trials. CCH is indicated for the treatment of adult men (>18 years old) with Peyronie’s disease having a palpable plaque and curvature deformity ? 30° at baseline [2]. Hereby we present three cases of PD in teenagers (15-17 years old) effectively treated with CCH.